Humacyte, Inc. (NASDAQ:HUMA) is one of the 11 Best High Volume Penny Stocks to Buy Now. On March 17, 2026, Humacyte, Inc.

On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when ...

Biomaterials are specifically engineered to support tissue, nerve and muscle regeneration across the body, yet physicians and ...

Researchers have successfully implanted a bioengineered tooth implant — that “grows” into the gum and fuses with existing nerves — into the mouths of rats. In a new paper published in the journal ...

To understand consumers’ attitudes toward a bioengineered crop pesticide for controlling Asian citrus psyllid, researchers are asking for volunteers to participate in focus groups in Riverside, ...

As the field of bioengineering continues to advance, scientists are making significant strides in growing organs for transplants. Among the most promising developments is the growth of lungs in the ...

For the estimated 12.7 million people around the world who are blind due to corneal stromal disease, a transplanted cornea from a human donor is the only way of regaining vision. But just one in 70 ...